360 ONE Asset invests Rs 170 cr in Paras Healthcare

IMT News Desk
IMT News Desk
· 1 min read
Coins in bottles with trading graph. financial investment concept use for background.

The transaction includes both primary capital infusion and a secondary component, including a partial exit by an existing investor

360 ONE Asset, a wholly-owned subsidiary of 360 ONE WAM, has completed an investment of Rs 170.60 crore in Paras Healthcare, a leading multispecialty hospital chain in North India. The transaction includes both primary capital infusion and a secondary component, including a partial exit by an existing investor.

Founded by Dr Dharminder Nagar, a seasoned entrepreneur with deep expertise in healthcare delivery, Paras Healthcare operates more than 2,000 beds across eight hospitals in Tier I and Tier II cities in North India. The group has built a strong reputation for offering accessible, high-quality medical care with an emphasis on affordability, underpinned by an asset-light business model with strong unit economics.

Umesh Agrawal, Senior Fund Manager & Strategy Head – Financial Services & Industrials, 360 ONE Asset, said, “This marks our seventh investment in the Indian healthcare services segment, reaffirming our strong conviction in the sector’s long-term potential. We are proud to partner with Paras Healthcare in expanding access to affordable quality care to under-served customers. This investment is also the latest from our market-leading Pre-IPO strategy.”

Read Next

India Willing to Open Its Market to High-Quality Innovative Pharma Products, Says Commerce Minister Goyal
News
June 9, 2026

India Willing to Open Its Market to High-Quality Innovative Pharma Products, Says Commerce Minister Goyal

India is prepared to welcome high-quality and innovative pharmaceutical products from the global industry in exchange for preferential access for its domestic drug exports, Commerce and Industry Minister Piyush Goyal announced on Monday. Speaking at the Pharmaceutical Promotion Council Ambassadors meeting, Goyal indicated that India’s pharmaceutical market size could potentially expand to USD 120 billion […]
Article by: IMT News Desk
AIIMS Study Reveals How Air Pollution Damages the Placenta and Changes Babies Before Birth
News
June 9, 2026

AIIMS Study Reveals How Air Pollution Damages the Placenta and Changes Babies Before Birth

A groundbreaking study by researchers at All India Institute of Medical Sciences (AIIMS Delhi) has revealed that air pollution can damage the placenta, restrict fetal growth, and increase pregnancy complications, with effects that may extend well beyond birth. The research, published in EMBO Molecular Medicine and funded by ICMR, examined how urban air pollution impacts […]
Article by: IMT News Desk
P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses
News
June 9, 2026

P. D. Hinduja Hospital & Dr. Homi Bhabha State University join hands to conduct specialized Postgraduate Allied Health Courses

P. D. Hinduja Hospital & Medical Research Centre signed a memorandum of understanding with Dr. Homi Bhabha State University (HBSU) to jointly conduct postgraduate allied (paramedical) health courses. The MoU aims to address the growing demand for skilled healthcare professionals and strengthen the quality of paramedical education in India. The program, expected to commence in […]
Article by: IMT News Desk
Immuneel Therapeutics secures over ₹100 Crore Series B Funding
News
June 9, 2026

Immuneel Therapeutics secures over ₹100 Crore Series B Funding

Immuneel Therapeutics announced the successful close of its ₹100 crore plus Series B financing. The round saw participation from new investors, including Singularity AMC, Rainmatter by Zerodha, and several High-Net-Worth Individuals, alongside strong continued support from existing investors, including Kiran Mazumdar-Shaw, Eight Roads Ventures, and F-Prime Capital. The financing will directly fund key strategic priorities: […]
Article by: IMT News Desk